Jencycla Tablet
Product Images NDC 68180-877

7 FDA label images from Lupin Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Jencycla (NDC 68180-877). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lupin Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Norethindrone (223eb6ba F676 4483 9511 55ab00a1debc 01)

Norethindrone (223eb6ba F676 4483 9511 55ab00a1debc 01)
Chemical structure of norethindrone, showing its molecular framework with labeled functional groups including hydroxyl (OH), methyl (CH3), and an alkyne group (C≡CH).*
FDA Label Image

Image (223eb6ba F676 4483 9511 55ab00a1debc 02)

FDA Label Image

Norethindrone (223eb6ba F676 4483 9511 55ab00a1debc 03)

Norethindrone (223eb6ba F676 4483 9511 55ab00a1debc 03)
Chemical structure of norethindrone, the active ingredient in Jencycla. The diagram shows the molecular structure with labeled functional groups including hydroxyl, methyl, and an alkyne group.*
FDA Label Image

Direction For Starting Pops (223eb6ba F676 4483 9511 55ab00a1debc 04)

Direction For Starting Pops (223eb6ba F676 4483 9511 55ab00a1debc 04)
An instructional diagram for Jencycla showing a 28-day calendar layout with four rows labeled Week 1 to Week 4 and columns for days Sunday through Saturday. Circles represent pill positions for each day. Instructions indicate if the period starts on a day other than Sunday, a day label strip should be placed starting with the first day of the period in the designated area.*
FDA Label Image

Image (223eb6ba F676 4483 9511 55ab00a1debc 05)

FDA Label Image

Image (223eb6ba F676 4483 9511 55ab00a1debc 06)

Image (223eb6ba F676 4483 9511 55ab00a1debc 06)
Flat packaging label for Jencycla 0.35 mg oral tablets by Lupin Pharmaceuticals, Inc. The label includes the proprietary name Jencycla with the active ingredient norethindrone tablets USP, strength 0.35 mg. It specifies Rx only and package quantity as 3 blisters of 28 tablets each. The label displays barcodes, NDC 68180-877-73, and indicates manufacturing and distribution details by Lupin Pharmaceuticals, Inc.*
FDA Label Image

Image (223eb6ba F676 4483 9511 55ab00a1debc 07)

Image (223eb6ba F676 4483 9511 55ab00a1debc 07)
Jencycla 0.35 mg tablets packaging label showing the lidding foil side with product name, strength, and manufacturer Lupin Pharmaceuticals, Inc. It includes storage instructions, a barcode, and an imprint of the NDC 68180-877-71. The forming foil/PVC side shows a blister pack design with days of the week for a 4-week dosing cycle.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.